Epigenetic therapy of acute myeloid leukemia using 5-aza-2'-deoxycytidine (decitabine) in combination with inhibitors of histone methylation and deacetylation

被引:0
作者
Richard L Momparler
Sylvie Côté
Louise F Momparler
Youssef Idaghdour
机构
[1] Université de Montréal,Département de Pharmacologie
[2] Service d’hématologie/oncologie,Centre de recherche
[3] New York University,Department of Biology
[4] Saadiyat Island,undefined
来源
Clinical Epigenetics | 2014年 / 6卷
关键词
5-aza-2’-deoxcytidine; 3-deazaneplanocin-A; Decitabine; Epigenetic therapy; EZH2; Histone deacetylase inhibitors; Myeloid leukemia;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 412 条
[1]  
Esteller M(2008)Epigenetics in cancer N Engl J Med 358 1148-1159
[2]  
Baylin SB(2011)A decade of exploring the cancer epigenome-biological and translational implications Nat Rev Cancer 11 726-734
[3]  
Jones PA(2010)DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia Cancer Cell 17 13-27
[4]  
Figueroa ME(2010)Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia Leukemia 24 932-941
[5]  
Lugthart S(2004)Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'- deoxycytidine (decitabine) in hematopoietic malignancies Blood 103 1635-1640
[6]  
Li Y(2010)Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia J Clin Oncol 28 556-561
[7]  
Erpelinck-Verschueren C(2010)Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine Proc Natl Acad Sci U S A 107 7473-7478
[8]  
Deng X(2012)A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy Haematologica 97 393-401
[9]  
Christos PJ(2012)Epigenetic therapy leaps ahead with specific targeting of EZH2 Cancer Cell 22 569-570
[10]  
Schifano E(2010)Polycomb group proteins: Multi-faceted regulators of somatic stem cells and cancer Cell Stem Cell 7 299-313